Icono ... no answers here, just more questions also.

So what's next? Another study of some kind, bolt-on, brief P3 or P4 (with NDA?)? Not going straight to NDA right?

Who/when will a partner (or buyer) come along? ... gotta happen soon to move the train down the tracks right, in one manner/flavor or another?

Multiple BT applications? ... yes, gotta believe there were app's for multiple cardio and renal indications? Right? ... getting more and more excited for the eGFR/renal data (March?).

Maybe this actually will be a 2 or 3 bagger, just not the path we hoped and expected back in the early autumn?  

Lots of questions still, but other than financing, all the questions are fun ones now, at least in my mind ... it seems nearly certain that this will not be a catastrophic business/investment failure, and highly likely to offer a handsome reward for the stout of heart who have steadfastly believed and endured.

Ohhhhh Cananda :) ...... hope to see a Nobel Prize resting in Calgary down the road.